Skip to main content
Top
Published in: AIDS and Behavior 4/2006

01-07-2006

Perceptions About the Acceptability of Assessments of HIV Medication Adherence in Lilongwe, Malawi and Chennai, India

Authors: Steven A. Safren, Ph.D., N. Kumarasamy, Mina Hosseinipour, Meaghan M. Harwood, Irving Hoffman, Marybeth McCauley, Allan Jumbe, Christina Nyirenda, Matthew J. Mimiaga, Suniti Solomon, David Celentano, Kenneth H. Mayer

Published in: AIDS and Behavior | Issue 4/2006

Login to get access

Abstract

Little research exists on acceptability issues related to assessments of adherence to ART in resource-poor settings. To help prepare for two large-scale, multisite ART intervention trials, this qualitative study of individuals in Chennai, India (49 men, 11 women; 33 taking ART, 27 not) and Lilongwe, Malawi (5 men, 5 women, all taking ART) examined potential limitations of different types of adherence assessments: an adherence questionnaire, a pill diary, a pillbox, an electronic pill cap, and a medication punch card. Many participants reported that the various assessments would be acceptable. Potential limitations included issues surrounding literacy, the desire to appease one’s medical provider, privacy and stigma, and “cheating.” These potential limitations are similar to the limitations of these assessments in Western settings. However, the data highlight the need to consider individual patient level concerns when assessing ART adherence in different cultural settings. Innovative ways of monitoring adherence while maintaining standardization across sites are required in multisite trials.
Literature
go back to reference Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423.CrossRefPubMed Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417–1423.CrossRefPubMed
go back to reference Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.CrossRefPubMed Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366.CrossRefPubMed
go back to reference Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., and Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13, 271–278.CrossRefPubMed Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., and Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13, 271–278.CrossRefPubMed
go back to reference Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al., the Patient Care Committee and Adherence Working Group of the Adult AIDS Clinical Trials Group. (2000a). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255-266.CrossRefPubMed Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al., the Patient Care Committee and Adherence Working Group of the Adult AIDS Clinical Trials Group. (2000a). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255-266.CrossRefPubMed
go back to reference Chesney, M. A., Morin, M., and Sherr, L. (2000b). Adherence to HIV combination therapy. Social Science and Medicine, 50, 1599–1605.CrossRefPubMed Chesney, M. A., Morin, M., and Sherr, L. (2000b). Adherence to HIV combination therapy. Social Science and Medicine, 50, 1599–1605.CrossRefPubMed
go back to reference Cramer, J. A., Mattson, R. H., Prevey, M. L., Scheyer, R. D., and Ouellette, V. L. (1989). How often is medication taken as prescribed? A novel assessment technique. Journal of the American Medical Association, 261, 3273–3277.CrossRefPubMed Cramer, J. A., Mattson, R. H., Prevey, M. L., Scheyer, R. D., and Ouellette, V. L. (1989). How often is medication taken as prescribed? A novel assessment technique. Journal of the American Medical Association, 261, 3273–3277.CrossRefPubMed
go back to reference Giordano, T. P., Guzman, D., Clark, R., Charlebois, E. D., and Bangsberg, D. R. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5, 74–79.CrossRefPubMed Giordano, T. P., Guzman, D., Clark, R., Charlebois, E. D., and Bangsberg, D. R. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5, 74–79.CrossRefPubMed
go back to reference Halkitis, P. N. (1999). The triangulation of measurement of antiretroviral adherence. Paper presented at the American Psychological Association, Boston, MA. Halkitis, P. N. (1999). The triangulation of measurement of antiretroviral adherence. Paper presented at the American Psychological Association, Boston, MA.
go back to reference Inui, T. S., Carter, W. B., and Pecoraro, R. E. (1981). Screening for noncompliance among patients with hypertension: Is self-report the best available measure?. Medical Care, 19, 1061–1064.PubMedCrossRef Inui, T. S., Carter, W. B., and Pecoraro, R. E. (1981). Screening for noncompliance among patients with hypertension: Is self-report the best available measure?. Medical Care, 19, 1061–1064.PubMedCrossRef
go back to reference Kumarasamy, N., Safren, S., Raminani, S. R., Pickard, R., James, R., Krishnan, A., et al. (2005). Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: A qualitative study. AIDS Patient Care and STDS, 19, 526–537.CrossRefPubMed Kumarasamy, N., Safren, S., Raminani, S. R., Pickard, R., James, R., Krishnan, A., et al. (2005). Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: A qualitative study. AIDS Patient Care and STDS, 19, 526–537.CrossRefPubMed
go back to reference Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., et al. (2004). Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting. Journal of Acquired Immune Deficiency Syndrome, 36, 1100–1102.CrossRef Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., et al. (2004). Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting. Journal of Acquired Immune Deficiency Syndrome, 36, 1100–1102.CrossRef
go back to reference Paterson, D. L., Swindells, S., Mohr, J., Vergis, E. N., Squire, C., Wagener, M. M., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed Paterson, D. L., Swindells, S., Mohr, J., Vergis, E. N., Squire, C., Wagener, M. M., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMed
go back to reference Roth, H. P., and Caron, H. S. (1978). Accuracy of doctors’ estimates and patients’ statements on adherence to a drug regimen. Clinical Pharmacology and Therapeutics, 23, 361–370.PubMed Roth, H. P., and Caron, H. S. (1978). Accuracy of doctors’ estimates and patients’ statements on adherence to a drug regimen. Clinical Pharmacology and Therapeutics, 23, 361–370.PubMed
go back to reference Rudd, P., Ahmed, S., Zachary, V., Barton, C., and Bonduelle, D. (1990). Improved compliance measures: Applications in an ambulatory hypertensive drug trial. Clinical Pharmacology and Therapeutics, 48, 676–685.PubMedCrossRef Rudd, P., Ahmed, S., Zachary, V., Barton, C., and Bonduelle, D. (1990). Improved compliance measures: Applications in an ambulatory hypertensive drug trial. Clinical Pharmacology and Therapeutics, 48, 676–685.PubMedCrossRef
go back to reference Safren, S. A., Hendriksen, E. S., DeSousa, N., Boswell, S. L., and Mayer, K. H. (2003). Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care, 15, 787–793.CrossRefPubMed Safren, S. A., Hendriksen, E. S., DeSousa, N., Boswell, S. L., and Mayer, K. H. (2003). Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care, 15, 787–793.CrossRefPubMed
go back to reference Safren, S. A., Kumarasamy, N., James, R., Raminani, S. R., Solomon, S., and Mayer, K. H. (2005). ART adherence, demographic variables, and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care, 17, 853–862.PubMed Safren, S. A., Kumarasamy, N., James, R., Raminani, S. R., Solomon, S., and Mayer, K. H. (2005). ART adherence, demographic variables, and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care, 17, 853–862.PubMed
go back to reference Safren, S. A., Otto, M. W., Worth, J., Salomon, E., Johnson, W., Mayer, K., et al. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life Steps and medication monitoring. Behavioral Research and Therapy, 39, 1151–1162.CrossRef Safren, S. A., Otto, M. W., Worth, J., Salomon, E., Johnson, W., Mayer, K., et al. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life Steps and medication monitoring. Behavioral Research and Therapy, 39, 1151–1162.CrossRef
go back to reference Stephenson, B. J., Rowe, B. H., Haynes, R. B., Macharia, W. M., and Leon, G. (1993). Is this patient taking the treatment as prescribed?. Journal of the American Medical Association, 269, 2779–2781.CrossRefPubMed Stephenson, B. J., Rowe, B. H., Haynes, R. B., Macharia, W. M., and Leon, G. (1993). Is this patient taking the treatment as prescribed?. Journal of the American Medical Association, 269, 2779–2781.CrossRefPubMed
go back to reference Waterhouse, D. M., Calzone, K. A., Mele, C., and Brenner, D. E. (1993). Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology, 11, 2457–2458.PubMed Waterhouse, D. M., Calzone, K. A., Mele, C., and Brenner, D. E. (1993). Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology, 11, 2457–2458.PubMed
Metadata
Title
Perceptions About the Acceptability of Assessments of HIV Medication Adherence in Lilongwe, Malawi and Chennai, India
Authors
Steven A. Safren, Ph.D.
N. Kumarasamy
Mina Hosseinipour
Meaghan M. Harwood
Irving Hoffman
Marybeth McCauley
Allan Jumbe
Christina Nyirenda
Matthew J. Mimiaga
Suniti Solomon
David Celentano
Kenneth H. Mayer
Publication date
01-07-2006
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2006
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-006-9094-6

Other articles of this Issue 4/2006

AIDS and Behavior 4/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.